Teknoloji

Total Market Cap 1,213.0B
P/E (Weighted)Price to Earnings ratio. 100.00 Medyan: 100.00
P/B (Weighted)Price to Book ratio. 5.00 Medyan: 5.00
P/E (Arithmetic)Simple average P/E. 99.91
Avg Lothien ScoreFinancial health score (0-100). 43
Avg DamodaranDamodaran scoring model. 35
Avg PotentialExpected upside potential %. -32.8%
Avg Dalio ScoreDalio debt cycle score. 72
Distributions
Lothien Distribution
0–25
1
25–40
11
40–55
24
55–70
2
70–100
0
Damodaran Distribution
0–25
4
25–40
22
40–55
12
55–70
0
70–100
0
Upside Potential
-100% – -20%
32
-20% – +0%
3
+0% – +20%
1
+20% – +50%
1
+50%+
1

Data date 2026-10-16 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-16
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
EMBRAC_B
87.82 17.9B — 10.30 41.92 -39.2% 11.0% 63 26 196.05 +69.0% 64 0.10
TIETOS
207.20 23.6B 93.76 21.68 68.71 15.0% 10.9% 58 40 177.61 -10.3% 68 0.63
PACT
139.20 3.5B 100.00 36.33 74.90 25.1% 12.0% 55 46 99.43 -20.6% 81 0.55
ERIC_A
98.10 324.4B 100.00 35.09 84.40 24.9% 10.5% 54 48 65.19 -24.2% 84 0.38
HACK
57.20 16.5B 96.20 128.06 87.50 522.7% 11.1% 52 50 41.82 -19.4% 100 0.02
KAMBI
156.00 4.2B 100.00 26.34 73.21 9.3% 12.1% 52 32 109.00 -21.7% 94 0.05
TGSO
138.50 27.2B 100.00 15.72 45.18 3.6% 10.9% 51 32 144.76 +3.0% 59 0.41
ATEAO
164.40 18.3B 100.00 48.91 84.93 19.8% 11.0% 48 43 109.25 -24.2% 66 0.88
COFFEE_B
18.85 4.0B 100.00 12.41 86.88 2.1% 12.1% 47 25 12.36 -24.8% 87 0.00
VER
11.64 2.3B — 5.41 23.65 3.9% 11.0% 47 36 19.11 +37.9% 43 1.21
HTRO
40.03 8.7B 100.00 22.07 105.67 7.3% 11.9% 44 30 21.79 -32.8% 70 0.60
PLEJD
852.00 9.7B 100.00 118.48 275.34 37.3% 11.1% 44 43 256.79 -52.4% 99 0.11
VIT_B
290.80 10.8B 100.00 23.91 78.10 9.0% 10.8% 44 32 198.57 -22.8% 67 0.75
ADDT_B
328.40 84.5B 100.00 110.51 294.24 22.7% 10.5% 43 42 96.05 -53.1% 71 0.79
MTG_A
115.00 13.7B 100.00 13.64 86.50 7.5% 11.0% 43 37 74.86 -23.4% 54 0.42
MTG_B
115.20 13.7B 100.00 13.49 85.61 7.5% 11.0% 43 37 75.61 -23.0% 54 0.42
SECT_B
307.60 55.2B 100.00 268.42 683.16 110.3% 10.6% 43 39 76.90 -56.2% 97 0.05
ACAST
32.65 6.0B 100.00 54.59 1,499.65 2.0% 12.1% 42 21 8.16 -56.3% 75 0.10
ANOD_B
54.70 7.2B 100.00 28.62 72.46 11.6% 11.8% 42 35 39.26 -18.9% 57 1.11
EPEN
152.60 4.9B 100.00 32.47 198.72 11.3% 12.0% 42 33 55.25 -47.9% 66 0.43
HMS
557.50 28.0B 100.00 85.17 377.96 14.2% 11.0% 42 29 147.00 -55.2% 65 0.59
IVSO
259.00 12.0B 100.00 115.15 286.45 41.4% 11.1% 42 45 76.67 -52.8% 96 0.06
PDX
137.00 14.5B 100.00 73.43 112.26 11.9% 11.1% 42 29 68.93 -37.3% 89 0.07
DYVOX
86.85 9.2B 100.00 145.86 192.00 19.1% 12.0% 41 37 31.41 -47.9% 68 1.55
LIME
256.50 3.4B 100.00 104.36 158.58 33.1% 12.1% 41 47 104.58 -44.4% 77 0.46
MILDEF
253.00 11.9B 100.00 81.32 302.46 14.6% 11.1% 40 32 73.10 -53.3% 72 0.42
NCAB
83.40 15.6B 100.00 117.71 345.37 15.7% 11.0% 40 33 22.79 -54.5% 71 0.88
SMCRT
14.28 2.3B 100.00 29.39 131.21 11.6% 12.1% 40 33 6.65 -40.1% 90 0.02
LAGR_B
230.00 45.2B 100.00 107.89 292.67 18.6% 11.0% 39 37 67.43 -53.0% 62 1.04
SAAB_B
610.50 323.7B 100.00 72.60 351.61 15.9% 10.6% 39 34 165.61 -54.7% 75 0.29
TRUE_B
23.77 7.7B 100.00 79.74 201.65 42.0% 12.1% 39 47 8.37 -48.6% 99 0.04
NOTE
181.10 5.2B 100.00 31.94 112.59 11.0% 11.9% 38 34 96.06 -33.8% 56 0.98
RAY_B
193.10 6.5B 100.00 92.63 264.46 28.9% 12.0% 38 44 59.30 -52.0% 83 0.46
SF
7.49 3.9B — 9.37 — 9.0% 11.5% 34 41 3.49 -27.2% 41 1.01
GOMX
12.46 2.2B 100.00 75.31 494.98 3.8% 12.4% 32 25 3.12 -54.0% 59 0.62
NOLA_B
57.10 13.8B 100.00 27.37 178.40 3.8% 10.3% 31 32 23.46 -42.4% 35 3.49
VENDO
215.20 44.2B — 29.02 — 11.6% 11.1% 29 32 56.77 -41.2% 82 0.17
SIVE
23.90 7.6B — 90.03 — -22.7% 12.1% 18 3 5.97 -32.3% 58 0.19

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.